Showing 257–272 of 281 results
-
-
-
Survivin 2B Peptide (AYACNTSTL)
The Survivin-2B peptide (AYACNTSTL) is a specific antigenic peptide recognized by CD8+ cytotoxic T lymphocytes (CTL) and is used in cancer immunotherapy.
-
Survivin Peptide (LMLGEFLKL)
Survivin (also known as BIRC5) is an evolutionarily conserved eukaryotic protein that is essential for cell division and can inhibit cell death. Normally it is only expressed in actively proliferating cells, but is upregulated in most, if not all cancers; consequently, it has received significant attention as a potential oncotherapeutic target.
-
SV40 T-Ag-derived NLS peptide
This peptide, a nuclear localization signal DNA tagged to this peptide efficiently translocates into the cell nucleus.
-
-
-
TAT peptide
The TAT peptide (GRKKRRQRRRPQ) is derived from the transactivator of transcription (TAT) of human immunodeficiency virus and is a Cell-penetrating peptides. Cell-penetrating peptides (CPPs) have been used to overcome the lipophilic barrier of the cellular membranes and deliver large molecules and even small particles inside the cell for their biological actions. CPPs are being used to deliver inside cell a large variety of cargoes such as proteins, DNA, antibodies, contrast (imaging) agents, toxins, and nanoparticular drug carriers including liposomes.
-
-
Tau peptide (244-274) (Repeat1 domain)
Tau Peptide (244-274) is a 31-amino acid long peptide derived from the Repeat 1 domain.
-
Tau peptide (275-305) (Repeat2 domain)
Tau Peptide (275-305) is a 31-amino acid long peptide derived from the Repeat 2 domain.
-
Tau peptide (306-336) (Repeat3 domain)
Tau Peptide (306-336) is a 31-amino acid long peptide derived from the Repeat 3 domain.
-
Tau peptide (337-368) (Repeat4 domain)
Tau Peptide (337-368) is a 32-amino acid long peptide derived from the Repeat 4 domain.
-
Tau peptide (45-73) (Exon2/Insert1 domain)
Tau Peptide (45-73) is a 29-amino acid long peptide derived from the Exon 2/Insert 1 domain.
-
-